Product Information
RELISTOR 150 MG TABLET is a brand product labeled by Salix Pharmaceuticals Inc., priced at $26.8914 per EA under NDC 65649015090. Its NADAC has been published 438 times since May 17, 2017.
Strength
150 mg/1
Manufacturer
Salix Pharmaceuticals Inc.NDC
65649015090
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
METHYLNALTREXONE BROMIDEApproval Type
New Drug (NDA)
FDA Application
NDA208271On Market Since
8/1/2008
Pharmacological Classes
Price Statistics
The NADAC for RELISTOR 150 MG TABLET has been published 438 times since May 17, 2017, and over the history we have for it it has risen 69.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.8914 per EA |
|---|---|
| All-time high | $26.9009 (Sep 10, 2025) |
| All-time low | $15.9022 (May 17, 2017) |
| 52-week high | $26.9009 |
| 52-week low | $26.8810 |
| Median price | $21.4665 |
| Average price | $21.5798 |
| Largest weekly change | +9.0% (Oct 11, 2017) |
| Weeks tracked | 438 |
| Tracking since | May 17, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Methylnaltrexone bromide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RELISTOR 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RELISTOR 150 MG TABLET, manufactured by Salix Pharmaceuticals Inc., is $26.8914 per EA (NDC 65649015090), effective Oct 1, 2025.
How has the price of RELISTOR 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for RELISTOR 150 MG TABLET has risen 69.1%. It has been tracked across 438 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for RELISTOR 150 MG TABLET?
Since May 17, 2017, the NADAC for RELISTOR 150 MG TABLET has ranged from a low of $15.9022 (May 17, 2017) to a high of $26.9009 (Sep 10, 2025), with a median of $21.4665 per EA.
Are there cheaper alternatives to RELISTOR 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RELISTOR 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures RELISTOR 150 MG TABLET?
RELISTOR 150 MG TABLET (NDC 65649015090) is labeled by Salix Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification